Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Specific Gut Bacterium Linked to Irritable Bowel Syndrome

By LabMedica International staff writers
Posted on 08 Dec 2020
The incidence of Irritable Bowel Syndrome (IBS) steeply increases following a gastroenteritis episode, suggesting a possible causative role for microbial perturbation. Gut microbiota composition studies overwhelmingly rely on fecal material.

Fecal and mucus-associated bacteria represent distinctive populations, with the latter more likely to influence the epithelium. In particular, bacterial presence in the inner mucus layer might result in epithelial stress and immune activation. Analyses of fecal microbiota have not demonstrated consistent alterations in IBS.

Biomedical scientists at the University of Gothenburg (Gothenburg, Sweden) and their colleagues prospectively included 62 IBS patients and 31 normal controls that underwent sigmoidoscopy with sampling of biopsies in methanol-Carnoy for future histology/immunohistochemistry and real-time PCR analysis. In a randomly selected subset of participants (the first/explorative cohort, IBS n=22, healthy n=14), mucus was collected from ex vivo sigmoid colon biopsies and analyzed by mass spectrometry (MS).

Mucus samples were prepared for MS according to a modified version of the Filter-Aided Sample Preparation (FASP) protocol. Nano-liquid chromatography-tandem MS was performed on a Q-Exactive instrument (Thermo Fisher Scientific, Bremen, Germany). Histology and immunohistochemistry was performed on tissue sections. Sections were examined using an Eclipse E-1000 epifluorescent microscope (Nikon, Tokyo, Japan). All PCR reactions were carried out in triplicate, using a Bio-Rad CFX96 Real-Time System (Bio-Rad, Hercules., CA, USA).

The investigators reported that metaproteomic analysis of colon mucus samples identified peptides from potentially pathogenic Brachyspira species in a subset of patients with IBS. Using multiple diagnostic methods, mucosal Brachyspira colonization was detected in a total of 19/62 (31%) patients with IBS from two prospective cohorts, versus 0/31 healthy volunteers. The prevalence of Brachyspira colonization in IBS with diarrhea (IBS-D) was 40% in both cohorts. Brachyspira attachment to the colonocyte apical membrane was observed in 20% of patients with IBS and associated with accelerated oro-anal transit, mild mucosal inflammation, mast cell activation and alterations of molecular pathways linked to bacterial uptake and ion–fluid homeostasis. According to species discrimination by real-time PCR, 50% of patients with spirochetosis were colonized by B. pilosicoli; others had either B. aalborgi or the closely related, unconfirmed, species B. hominis.

Magnus Simrén, MD, PhD, a Professor of Gastroenterology, and a co-author of the study, said, “The study suggests that the bacterium may be found in about a third of individuals with IBS. We want to see whether this can be confirmed in a larger study, and we're also going to investigate whether, and how, Brachyspira causes symptoms in IBS. Our findings may open up completely new opportunities for treating and perhaps even curing some IBS patients, especially those who have diarrhea.”

The authors concluded that mucosal Brachyspira colonization was significantly more common in IBS and associated with distinctive clinical, histological and molecular characteristics. The observations suggest a role for Brachyspira in the pathogenesis of IBS, particularly IBS-D. The study was published on November 11, 2020 in the journal GUT.

Related Links:
University of Gothenburg
Thermo Fisher Scientific
Nikon
Bio-Rad



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mumps Virus Test
ZEUS ELISA Mumps IgG Test System
New
Immunofluorescence Analyzer
MPQuanti
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.